MedTrace Logo

Comparison of AuraGain With I-gel for Pediatric Patients

NCT03294226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2018-05-11

No results posted yet for this study

Summary

Children from 6 months to 6 years are randomly allocated into AuraGain group or I-gel group. After anesthetic induction without neuromuscular blocking agent, assigned device in inserted by skillful anesthesiologist. The outcome measures are recorded and analysed.

Conditions

  • General Anesthesia

Interventions

DEVICE

AuraGain

After anesthetic induction without neuromuscular blocking agent, AuraGain is inserted.

DEVICE

I-gel

After anesthetic induction without neuromuscular blocking agent, I-gel is inserted.

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Won Uk Koh, M.D., Ph.D. · University of Ulsan, College of Medicine, Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-25
Primary Completion
2018-03-23
Completion
2018-03-24

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03294226 on ClinicalTrials.gov